A PROTOCOL FOR PERFORMING EXTENDED LYMPH NODE DISSECTION USING PRIMARY TUMOR PATHOLOGICAL FEATURES FOR PATIENTS TREATED WITH RADICAL NEPHRECTOMY FOR CLEAR CELL RENAL CELL CARCINOMA-Reference-Cited by-同舟云学术

A PROTOCOL FOR PERFORMING EXTENDED LYMPH NODE DISSECTION USING PRIMARY TUMOR PATHOLOGICAL FEATURES FOR PATIENTS TREATED WITH RADICAL NEPHRECTOMY FOR CLEAR CELL RENAL CELL CARCINOMA

Published:2004-08 Issue:2 Volume:172 Page:465-469
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BLUTE MICHAEL L.¹,LEIBOVICH BRADLEY C.¹,CHEVILLE JOHN C.¹,LOHSE CHRISTINE M.¹,ZINCKE HORST¹

Affiliation:

1. From the Departments of Urology (MLB, BCL, HZ), Pathology (JCC) and Health Sciences Research (CML), Mayo Clinic, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference14 articles.

1. The results of radical nephrectomy for renal cell carcinoma;Robson;J Urol,1969

2. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma;Ward;J Urol,2002

3. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases;Giberti;Eur Urol,1997

4. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group;Blom;Eur Urol,1999

5. Renal cell carcinoma with retroperitoneal lymph nodes: the role of lymph node dissection;Pantuck;J Urol,2003

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Cancer;Tata Memorial Centre Textbook of Oncology;2024

2. Should Patients with Renal Cell Carcinoma and Pathological Nodal Invasion Be Classified As Having Stage IV Disease?;Annals of Surgical Oncology;2023-06-08

3. The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma;Journal of Clinical Medicine;2023-05-29

4. A Novel Predictive Model of Pathological Lymph Node Metastasis Constructed with Preoperative Independent Predictors in Patients with Renal Cell Carcinoma;Journal of Clinical Medicine;2023-01-05

5. Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model;Journal of Urology;2023-01